|
⚲
|
| Keyboard |
| Clarus Ventures LLC
✚
|
|
|---|---|
| CRD # | 160980 |
| SEC # | 801-114471 |
| CIK # | 0001431431 |
| AUM | 805.6 M (2026-03-30) |
| Employees | 31 (68% Investors, 0% Brokers) |
| Phone | 617-949-2200 |
| Address | 314 Main St Cambridge, MA 02142 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Clarus IV-A LP | [2018-03-28] | 789.7 M | 217.3 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-B LP | [2018-03-28] | 789.7 M | 139.5 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $500,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-C LP | [2018-03-28] | 789.7 M | 257.5 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $250,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-D LP | [2018-03-28] | 789.7 M | 51.4 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $7,700,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus Defined Exit I LP | [2015-03-23] | 100.0 M | 63.9 M |
| Offered $100,000,000 · Filed 2014-08-05 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $14,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus de II LP | [2015-03-23] | 40.0 M | 26.8 M |
| Offered $40,000,000 · Filed 2014-09-18 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $40,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus Lifesciences III LP | [2015-03-23] | 234.2 M | 24.8 M |
| Offered $375,000,000 · Filed 2014-06-19 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $140,840,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus Lifesciences II LP | [2012-03-22] | 23.8 M | |
| VC | Clarus Lifesciences I LP | 2012-03-22 | 0.5 M | |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 0.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 0.8 |
| By Discretionary | ||
| Discretionary | 9 | 0.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 0.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.8 | |
| Total | 9 | 0.8 |
| Limited Partners | 2011 - 2026 |
|---|---|
| California Public Employees' Retirement System | |
| New York State Common Retirement Fund |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Nicholas Galakatos | Executive Officer | 53 | 3 | |
| Robert Liptak | Executive Officer | 23 | 3 | |
| Kurt Wheeler | Executive Officer | 25 | 2 | |
| Scott Requadt | Executive Officer | 21 | 2 | |
| Dennis Henner | Executive Officer | 17 | 2 | |
| Emmett Cunningham | Executive Officer | 14 | 2 | |
| Nicholas Simon | Executive Officer | 12 | 2 | |
| Clarus Ventures III LLC | Director | 2 | 2 | |
| Clarus IV GP LP | Director | 4 | 1 | |
| Clarus IV GP LLC | Director | 4 | 1 | |
| Clarus Ventures de GP LLC | Director | 2 | 1 | |
| Clarus Ventures de GP LP | Director | 2 | 1 | |
| Clarus Ventures III GP LP | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001431431] | |
| 13F-NT | [0001431431] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| LEI | 9845004AEBAE1D8C4E60 |
| Related Firms | State | AUM |
|---|---|---|
|
Blackstone Life Sciences Advisors LLC
✚
|
MA | 13.19 B |
|
Clarus Ventures LLC
✚
|
MA | 805.6 M |
| Comparable Firms | State | AUM |
|---|---|---|
|
American Ventures IM LLC
✚
|
FL | 813.7 M |
|
Sunflower Wealth Advisors LLC
✚
|
KS | 812.8 M |
|
Horizon Technology Finance Management LLC
✚
|
CT | 811.1 M |
|
EFG Asset Management North America Corp
✚
|
OR | 808.9 M |
|
Polen Capital CLO Management LLC
✚
|
MA | 808.4 M |
|
OHA Private Credit Advisors II LP
✚
|
NY | 805.2 M |
|
Fintech Collective Management LLC
✚
|
NY | 800.8 M |
|
ICR Partners LLC
✚
|
TN | 798.7 M |
|
337 Frontier Capital LP
✚
|
NY | 795.3 M |
|
Friends & Family Capital Management LLC
✚
|
CA | 793.8 M |